1. Home
  2. OGN vs PRGS Comparison

OGN vs PRGS Comparison

Compare OGN & PRGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.43

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Progress Software Corporation (DE)

PRGS

Progress Software Corporation (DE)

HOLD

Current Price

$29.66

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGN
PRGS
Founded
1923
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
OGN
PRGS
Price
$13.43
$29.66
Analyst Decision
Hold
Buy
Analyst Count
5
6
Target Price
$11.40
$49.50
AVG Volume (30 Days)
2.6M
600.4K
Earning Date
05-07-2026
03-30-2026
Dividend Yield
0.60%
N/A
EPS Growth
N/A
7.79
EPS
0.55
0.53
Revenue
$6,216,000,000.00
$397,572,000.00
Revenue This Year
$0.45
$3.70
Revenue Next Year
$1.67
$1.08
P/E Ratio
$24.42
$56.00
Revenue Growth
N/A
N/A
52 Week Low
$5.69
$23.82
52 Week High
$13.49
$65.50

Technical Indicators

Market Signals
Indicator
OGN
PRGS
Relative Strength Index (RSI) 72.03 44.62
Support Level $10.05 $26.18
Resistance Level $13.46 $30.05
Average True Range (ATR) 0.05 1.43
MACD -0.11 -0.28
Stochastic Oscillator 57.14 9.95

Price Performance

Historical Comparison
OGN
PRGS

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

About PRGS Progress Software Corporation (DE)

Progress Software Corp provides software products that enable customers to develop, deploy, and manage AI-powered applications and digital experiences. The Company operates across North America, Latin America, Europe, the Middle East and Africa (EMEA), and Asia Pacific through subsidiaries and distributors, generating a majority of its revenue from the United States. Its product portfolio includes Progress Agentic RAG, Automate MFT, Chef, Corticon, DataDirect, Developer Tools, Flowmon, Kemp LoadMaster, MarkLogic, MOVEit, OpenEdge, Semaphore, ShareFile, Sitefinity, and WhatsUp Gold, offering solutions for application development, data connectivity, DevOps automation, managed file transfer, network security, and digital experience. It generates maximum revenue from the United States.

Share on Social Networks: